News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
oryzon
ORYZON to give updates on corporate progress in January
International
6º Sachs Annual Neuroscience Innovation Forum 12º Annual LifeSci Advisors Corporate Access Event…
Partners - Oryzon Genomics
Terinmun
PharmaMar leads the TERINMUN initiative, a research consortium in search of immunotherapies based on marine-derived compounds
Healthcare · Access to innovation · Innovative drugs · Financing · Corporate
The project has been approved in the call for public-private collaboration projects of the Ministry…
3p
3P Biopharmaceuticals among the 500 fastest growing companies in Spain
Corporate
This is the first year that the company appears in the ranking established by CEPYME
Partners - 3PBIOVIAN
foto oryzon
ORYZON awarded EU grant to further explore the role of iadademstat in oncological immunotherapy approaches
Healthcare · Access to innovation · Corporate
Project will assess the efficacy of iadademstat in combination with checkpoint inhibitors and/or…
Partners - Oryzon Genomics
pcb
Barcelona Science Park, a strategic hub for public R&D&i of excellence
Healthcare · Access to innovation · Talento · Corporate
2021 was a year full of challenges and milestones achieved for public research groups and…
Partners - Parc Científic de Barcelona
Equipo de GENESIS Biomed
GENESIS Biomed continues growing and adding value in biomedical sector
Healthcare · Access to innovation · Financing
Since it was established in May 2017, the company has worked on more than 253 consultancy projects…
Partners - Parc Científic de Barcelona
oryzon
ORYZON presents final data from Phase IIa ALICE trial in unfit AML patients with first-line treatment of iadademstat and azacitidine in oral presentation at ASH- 2022
Corporate
Clinical efficacy signals were robust, with an objective response rate (ORR) of 81%; of these, 64%…
Partners - Oryzon Genomics
inveready
Oxolife receives a 2.4M€ grant to develop a new treatment for infertility related to polycystic ovarian syndrome
Healthcare · Access to innovation · Corporate
Oxolife, in collaboration with Cordoba’s University, will advance from preclinical to phase II…
Partners - Inveready
hackaton
This was the Health Hackathon 2022
Healthcare · Corporate
Last Thursday, November 24, the Ramón y Cajal Hospital in Madrid hosted the Health Hackathon 2022